Atanis Biotech
Founded 2021 · 28 employees on LinkedIn · 1 known investors
Atanis Biotech develops FAST-PASE®, a blood-based allergy diagnostic test that measures how a patient's blood activates mast cells in response to specific food and other allergens, avoiding skin pricks and food challenges. The test targets common food allergens (egg, milk, peanut, cashew) and Alpha-gal red meat allergy, and is currently in development for use by patients and healthcare providers.
Founders & leadership
Atanis Biotech was founded in 2021 by Prof. Dr. Alexander Eggel, Prof. Dr. Thomas Kaufmann, and Prof. Dr. Jean-Pierre Kinet.
PD
Prof. Dr. Alexander EggelCo-Founder & Scientific Advisor
PD
Prof. Dr. Thomas KaufmannCo-Founder & Scientific Advisor
PD
Prof. Dr. Jean-Pierre KinetCo-founder & CEO
EE
Erwan EriauChief Operating Officer
DJ
Dr. Jonathan FriedlanderChief Business Officer
Investors · 1
Competitors · 2
by search overlap
IQVIA3 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Fortis Life Sciences3 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
Companies competing with Atanis Biotech for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Atanis Biotech do?
- Atanis Biotech develops FAST-PASE®, a blood-based allergy diagnostic test that measures how a patient's blood activates mast cells in response to specific food and other allergens, avoiding skin pricks and food challenges. The test targets common food allergens (egg, milk, peanut, cashew) and Alpha-gal red meat allergy, and is currently in development for use by patients and healthcare providers.
- Who founded Atanis Biotech?
- Atanis Biotech was founded by Prof. Dr. Alexander Eggel, Prof. Dr. Thomas Kaufmann, Prof. Dr. Jean-Pierre Kinet in 2021.
- Who are Atanis Biotech's investors?
- Atanis Biotech's investors include Allerfund Ventures, Llc.